Pre-earnings options volume in Harrow (HROW) Health is 2.7x normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating a move near 15.2%, or $8.04, after results are released. Median move over the past eight quarters is 17.0%.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HROW:
- HROW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Harrow price target raised to $55 from $45 at Lake Street
- Harrow price target raised to $65 from $45 at Craig-Hallum
- Harrow announces relaunch of TRIESENCE for vitrectomy visualization, inflamation
- Harrow announces expansion of corporate headquarters in Nashville